Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
0.6400
+0.0332 (5.47%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Nektar Therapeutics Market Cap

Nektar Therapeutics has a market cap or net worth of $118.44 million as of April 17, 2025. Its market cap has decreased by -37.99% in one year.

Market Cap
118.44M
Enterprise Value
43.68M
1-Year Change
-37.99%
Ranking
Category
Stock Price
$0.64

Market Cap Chart

Since December 1, 1998, Nektar Therapeutics's market cap has decreased from $478.60M to $118.44M, a decrease of -75.25%. That is a compound annual growth rate of -5.15%.

History

DateMarket Cap% Change
Apr 17, 2025118.40M-30.96%
Dec 31, 2024171.50M59.09%
Dec 29, 2023107.80M-74.62%
Dec 30, 2022424.80M-82.96%
Dec 31, 20212.49B-18.24%
Dec 31, 20203.05B-19.69%
Dec 31, 20193.80B-33.26%
Dec 31, 20185.69B-39.50%
Dec 29, 20179.40B401.47%
Dec 30, 20161.88B-16.61%
Dec 31, 20152.25B12.95%
Dec 31, 20141.99B51.06%
Dec 31, 20131.32B54.43%
Dec 31, 2012853.40M33.30%
Dec 30, 2011640.20M-47.19%
Dec 31, 20101.21B39.56%
Dec 31, 2009868.60M68.99%
Dec 31, 2008514.00M-16.91%
Dec 31, 2007618.60M-54.96%
Dec 29, 20061.37B-4.78%
Dec 30, 20051.44B-15.13%
Dec 31, 20041.70B122.51%
Dec 31, 2003763.80M70.57%
Dec 31, 2002447.80M-56.04%
Dec 31, 20011.02B-55.42%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 748.79B
UnitedHealth Group 411.76B
Johnson & Johnson 380.18B
AbbVie 306.32B
Novo Nordisk 284.50B
Abbott Laboratories 226.40B
AstraZeneca 210.38B
Novartis AG 210.23B
Market Cap Rankings